Prostate cancer is the second most common type of cancer in men and is predicted to result in an estimated 220,000 cases in the United States in 2015. A team of researchers recently published results of a randomized trial that assessed the safety and effectiveness of the active components in green tea to prevent prostate cancer development in men who have premalignant lesions.
SOURCE: Top Health News — ScienceDaily – Read entire story here.